Skip to content
TriangleGet started
← Full study record

NCT00866047 · BASELINE

Baseline characteristics

A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma · Source last updated 2017-03-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      58
    units
    Participants
groups
  1. description
    Brentuximab vedotin 1.8 mg/kg every 3 weeks by IV infusion
    id
    BG000
    title
    Brentuximab Vedotin
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          14
          upper Limit
          76
          value
          52.0
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Customized
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          33
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          7
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          48
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          2
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          19
      title
      0
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          38
      title
      1
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      2
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      3-5
    description
    0 = Normal activity 1. = Symptoms but ambulatory 2. = In bed \<50% of the time 3. = In bed \>50% of the time 4. = 100% bedridden 5. = Dead
    param Type
    NUMBER
    title
    Eastern Cooperative Oncology Group Performance Status
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      Positive
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          42
      title
      Negative
    description
    Immunophenotype status with respect to anaplastic lymphoma kinase (ALK) protein
    param Type
    NUMBER
    title
    ALK Status
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      58
    units
    Participants
groups
  1. description
    Brentuximab vedotin 1.8 mg/kg every 3 weeks by IV infusion
    id
    BG000
    title
    Brentuximab Vedotin
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          14
          upper Limit
          76
          value
          52.0
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Customized
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          25
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          33
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        American Indian or Alaska Native
      2. measurements
        1. group Id
          BG000
          value
          1
        title
        Asian
      3. measurements
        1. group Id
          BG000
          value
          0
        title
        Native Hawaiian or Other Pacific Islander
      4. measurements
        1. group Id
          BG000
          value
          7
        title
        Black or African American
      5. measurements
        1. group Id
          BG000
          value
          48
        title
        White
      6. measurements
        1. group Id
          BG000
          value
          0
        title
        More than one race
      7. measurements
        1. group Id
          BG000
          value
          2
        title
        Unknown or Not Reported
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race (NIH/OMB)
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          19
      title
      0
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          38
      title
      1
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      2
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          0
      title
      3-5
    description
    0 = Normal activity 1. = Symptoms but ambulatory 2. = In bed \<50% of the time 3. = In bed \>50% of the time 4. = 100% bedridden 5. = Dead
    param Type
    NUMBER
    title
    Eastern Cooperative Oncology Group Performance Status
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          16
      title
      Positive
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          42
      title
      Negative
    description
    Immunophenotype status with respect to anaplastic lymphoma kinase (ALK) protein
    param Type
    NUMBER
    title
    ALK Status
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice